Novel adiponectin-resistin (AR) and insulin resistance (IRAR) indexes are useful integrated diagnostic biomarkers for insulin resistance, type 2 diabetes and metabolic syndrome: a case control study.

The novel AR and IRAR indexes are cost-effective, precise, reproducible and reliable integrated diagnostic biomarkers of insulin sensitivity for screening subjects with increased risk of future development of T2DM and MS.

Saved in:
Bibliographic Details
Main Authors: Lau, Cia-Hin, Muniandy, Sekaran
Format: Article
Published: 2011
Subjects:
Online Access:http://eprints.um.edu.my/83/
http://www.ncbi.nlm.nih.gov/pubmed/21251282
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1831446075972517888
author Lau, Cia-Hin
Muniandy, Sekaran
author_facet Lau, Cia-Hin
Muniandy, Sekaran
author_sort Lau, Cia-Hin
building UM Library
collection Institutional Repository
content_provider Universiti Malaya
content_source UM Research Repository
continent Asia
country Malaysia
description The novel AR and IRAR indexes are cost-effective, precise, reproducible and reliable integrated diagnostic biomarkers of insulin sensitivity for screening subjects with increased risk of future development of T2DM and MS.
format Article
id my.um.eprints-83
institution Universiti Malaya
publishDate 2011
record_format eprints
spelling my.um.eprints-832011-02-25T07:26:07Z http://eprints.um.edu.my/83/ Novel adiponectin-resistin (AR) and insulin resistance (IRAR) indexes are useful integrated diagnostic biomarkers for insulin resistance, type 2 diabetes and metabolic syndrome: a case control study. Lau, Cia-Hin Muniandy, Sekaran R Medicine (General) The novel AR and IRAR indexes are cost-effective, precise, reproducible and reliable integrated diagnostic biomarkers of insulin sensitivity for screening subjects with increased risk of future development of T2DM and MS. 2011 Article PeerReviewed Lau, Cia-Hin and Muniandy, Sekaran (2011) Novel adiponectin-resistin (AR) and insulin resistance (IRAR) indexes are useful integrated diagnostic biomarkers for insulin resistance, type 2 diabetes and metabolic syndrome: a case control study. Cardiovascular Diabetology, 10 (1). p. 8. ISSN 1475-2840, DOI 21251282. http://www.ncbi.nlm.nih.gov/pubmed/21251282 21251282
spellingShingle R Medicine (General)
Lau, Cia-Hin
Muniandy, Sekaran
Novel adiponectin-resistin (AR) and insulin resistance (IRAR) indexes are useful integrated diagnostic biomarkers for insulin resistance, type 2 diabetes and metabolic syndrome: a case control study.
title Novel adiponectin-resistin (AR) and insulin resistance (IRAR) indexes are useful integrated diagnostic biomarkers for insulin resistance, type 2 diabetes and metabolic syndrome: a case control study.
title_full Novel adiponectin-resistin (AR) and insulin resistance (IRAR) indexes are useful integrated diagnostic biomarkers for insulin resistance, type 2 diabetes and metabolic syndrome: a case control study.
title_fullStr Novel adiponectin-resistin (AR) and insulin resistance (IRAR) indexes are useful integrated diagnostic biomarkers for insulin resistance, type 2 diabetes and metabolic syndrome: a case control study.
title_full_unstemmed Novel adiponectin-resistin (AR) and insulin resistance (IRAR) indexes are useful integrated diagnostic biomarkers for insulin resistance, type 2 diabetes and metabolic syndrome: a case control study.
title_short Novel adiponectin-resistin (AR) and insulin resistance (IRAR) indexes are useful integrated diagnostic biomarkers for insulin resistance, type 2 diabetes and metabolic syndrome: a case control study.
title_sort novel adiponectin-resistin (ar) and insulin resistance (irar) indexes are useful integrated diagnostic biomarkers for insulin resistance, type 2 diabetes and metabolic syndrome: a case control study.
topic R Medicine (General)
url http://eprints.um.edu.my/83/
http://www.ncbi.nlm.nih.gov/pubmed/21251282
url_provider http://eprints.um.edu.my/